DHA can then enter cancer cells via GLUT1, depleting the intracellular reducing potential of reduced GSH and nicotinamide adenine dinucleotide phosphate (NADPH), thereby increasing intracellular ROS. This evidence concerns the gene SLC2A1 and cancer.